{"id":"https://openalex.org/W1575865260","doi":null,"title":"Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.","display_name":"Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.","publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W1575865260","mag":"1575865260","pmid":"https://pubmed.ncbi.nlm.nih.gov/11300491"},"language":"en","primary_location":{"id":"pmid:11300491","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11300491","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Case Reports"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044479295","display_name":"Galina V. Yamshchikov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799765794","display_name":"University of Virginia Health System","ror":"https://ror.org/00wn7d965","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799765794"]},{"id":"https://openalex.org/I4390039272","display_name":"University of Virginia Cancer Center","ror":"https://ror.org/04w75nz84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039272"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G Yamshchikov","raw_affiliation_strings":["Department of Surgery, University of Virginia Health Sciences Center and Cancer Center, Charlottesville 22908, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, University of Virginia Health Sciences Center and Cancer Center, Charlottesville 22908, USA","institution_ids":["https://openalex.org/I2799765794","https://openalex.org/I4390039272","https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111284399","display_name":"Ladaisha Thompson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Thompson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111995410","display_name":"W. Gilles Ross","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W G Ross","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025387759","display_name":"Holly Galavotti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Galavotti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057560982","display_name":"William Aquila","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Aquila","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109690493","display_name":"Donna H. Deacon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Deacon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111462869","display_name":"Jennifer Caldwell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Caldwell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060863731","display_name":"James W. Patterson","orcid":"https://orcid.org/0000-0002-3290-3058","observed_orcids":["https://orcid.org/0000-0002-3290-3058"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J W Patterson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011931811","display_name":"Donald F. Hunt","orcid":"https://orcid.org/0000-0003-2815-6368","observed_orcids":["https://orcid.org/0000-0003-2815-6368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D F Hunt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5090865977","display_name":"Craig Lee Slingluff","orcid":"https://orcid.org/0000-0002-6664-4373","observed_orcids":["https://orcid.org/0000-0002-6664-4373"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C L Slingluff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7777,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.83913399,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"7","issue":"3 Suppl","first_page":"909s","last_page":"916s"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9193999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9193999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0471000000834465,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.023600000888109207,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9409999847412109},{"id":"https://openalex.org/keywords/long-term-survival","display_name":"long-term survival","score":0.7129999995231628},{"id":"https://openalex.org/keywords/natural-immune-response","display_name":"natural immune response","score":0.7279999852180481},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.7310000061988831},{"id":"https://openalex.org/keywords/gp100","display_name":"gp100","score":0.8299999833106995},{"id":"https://openalex.org/keywords/hla-a3","display_name":"HLA-A3","score":0.703000009059906},{"id":"https://openalex.org/keywords/memory-t-cells","display_name":"memory T cells","score":0.7699999809265137},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.8109999895095825},{"id":"https://openalex.org/keywords/peptide-specific-t-cells","display_name":"peptide-specific T cells","score":0.5849999785423279},{"id":"https://openalex.org/keywords/mhc-tetramers","display_name":"MHC tetramers","score":0.7099999785423279},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.48899999260902405},{"id":"https://openalex.org/keywords/clinical-trial-evaluation","display_name":"clinical trial evaluation","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.6574505567550659},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6175358295440674},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6039265990257263},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6016454100608826},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5512696504592896},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4968545734882355},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4895657002925873},{"id":"https://openalex.org/C2780849966","wikidata":"https://www.wikidata.org/wiki/Q170758","display_name":"Lymph node","level":2,"score":0.4614812731742859},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.4562850892543793},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44672688841819763},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4420824944972992},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.43288683891296387},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4130759537220001},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3696003556251526},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.12143632769584656},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007156","descriptor_name":"Immunologic Memory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D008207","descriptor_name":"Lymphatic Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008214","descriptor_name":"Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015791","descriptor_name":"HLA-A3 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016130","descriptor_name":"Immunophenotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016827","descriptor_name":"CD8 Antigens","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D017493","descriptor_name":"Leukocyte Common Antigens","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018845","descriptor_name":"CD11 Antigens","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D019041","descriptor_name":"L-Selectin","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11300491","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11300491","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Case Reports"},{"id":"mag:1575865260","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11300491","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6345134304","display_name":"PEPTIDE BASED VACCINES FOR STAGE IV MELANOMA","funder_award_id":"R01CA078519","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1521600055","https://openalex.org/W1524584806","https://openalex.org/W1525721830","https://openalex.org/W1573683919","https://openalex.org/W1588193878","https://openalex.org/W1932934724","https://openalex.org/W1967577151","https://openalex.org/W1975291026","https://openalex.org/W1983806918","https://openalex.org/W1990857452","https://openalex.org/W2003766121","https://openalex.org/W2018221216","https://openalex.org/W2050253058","https://openalex.org/W2059167513","https://openalex.org/W2063574986","https://openalex.org/W2066964346","https://openalex.org/W2067069532","https://openalex.org/W2075531452","https://openalex.org/W2107703986","https://openalex.org/W2123167369","https://openalex.org/W2126302947","https://openalex.org/W2162057142","https://openalex.org/W2162717294","https://openalex.org/W2164658014","https://openalex.org/W2165353512","https://openalex.org/W2167008563"],"related_works":["https://openalex.org/W1627619586","https://openalex.org/W2082384238","https://openalex.org/W2087792945","https://openalex.org/W2051700627","https://openalex.org/W7099396408","https://openalex.org/W2001753408","https://openalex.org/W2099508134","https://openalex.org/W2528209870","https://openalex.org/W2125757318","https://openalex.org/W2076730875"],"abstract_inverted_index":{"The":[0,92,217],"long-term":[1,61,232],"survival":[2],"of":[3,28,39,59,149,156,172,239,242],"some":[4],"patients":[5,193],"with":[6,50,139,154,170,194,222,249],"metastatic":[7,197],"melanoma":[8,19,62,198],"may":[9,246],"be":[10,106,247],"attributable":[11],"in":[12,31,87,142,145,164,204,230],"part":[13],"to":[14,18,105,160],"cellular":[15],"immune":[16,226],"responses":[17,47],"antigens.":[20],"However,":[21],"little":[22],"is":[23,34],"known":[24],"about":[25],"the":[26,43,75,127,240],"level":[27,241],"CTL":[29,243],"reactivity":[30],"vivo":[32],"that":[33,112,245],"required":[35],"for":[36,181],"immunological":[37],"control":[38],"tumor":[40,162,229,252],"progression.":[41],"In":[42,189],"present":[44],"report,":[45],"T-cell":[46,133,176,202],"were":[48,85,96,103],"evaluated":[49,98],"lymphocytes":[51,125],"obtained":[52],"from":[53,126,251],"tumor-involved":[54,89,166,205],"nodes":[55,206],"and":[56,102,117,169],"peripheral":[57,123,208],"blood":[58,124,209],"a":[60,88,119,136,146,165,173,223],"survivor.":[63,233],"Using":[64],"an":[65,237],"ELISPOT":[66],"assay,":[67],"naturally":[68],"occurring":[69],"functional":[70],"T":[71,94],"cells,":[72],"which":[73],"recognize":[74],"peptide":[76,141,213],"ALLAVGATK":[77,140],"(gp100(17-25))":[78],"plus":[79],"two":[80],"other":[81],"HLA-A3":[82],"restricted":[83],"peptides,":[84],"detected":[86],"lymph":[90,167],"node.":[91],"ALLAVGATK-reactive":[93],"cells":[95],"also":[97],"by":[99],"MHC-tetramers":[100],"staining":[101],"found":[104],"CD8+":[107],"CD45RO+":[108],"L-selectin(-)":[109],"CD11a+,":[110],"suggesting":[111],"they":[113],"are":[114,220],"antigen":[115],"experienced":[116],"have":[118],"memory":[120,175],"phenotype.":[121],"Unstimulated":[122],"same":[128],"patient":[129],"demonstrated":[130],"no":[131,200],"detectable":[132,201],"responses;":[134],"however,":[135],"single":[137],"stimulation":[138,214],"vitro":[143],"resulted":[144],"dramatic":[147],"expansion":[148],"peptide-reactive":[150],"CTLs.":[151],"This":[152],"patient,":[153],"evidence":[155,171],"tumor-reactive":[157],"CTLs":[158],"targeted":[159],"several":[161],"antigens":[163],"node":[168],"circulating":[174],"response,":[177],"has":[178],"remained":[179],"disease-free":[180],"6":[182],"years,":[183],"despite":[184],"prior":[185],"bulky":[186],"nodal":[187],"metastasis.":[188],"contrast,":[190],"three":[191],"HLA-A3+":[192],"rapidly":[195],"progressive":[196],"had":[199],"response":[203,227,244],"or":[207],"lymphocytes,":[210],"even":[211],"after":[212],"ex":[215],"vivo.":[216],"presented":[218],"data":[219,235],"consistent":[221],"systemic":[224],"polyvalent":[225],"against":[228],"this":[231],"These":[234],"provide":[236],"estimate":[238],"associated":[248],"protection":[250],"recurrence.":[253]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}